AMA
Pawlus-Ruszel Z, Łanocha M, Kruczek W, Frątczak A, Bergler-Czop B, Miziołek B. To kill two birds with one stone: a case report on the use of dupilumab in eczematous eruption and managing anti- PD-1 adverse effects in a melanoma patient. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2026;43(5):584-587. doi:10.5114/ada.2026.165991.
APA
Pawlus-Ruszel, Z., Łanocha, M., Kruczek, W., Frątczak , A., Bergler-Czop, B., & Miziołek, B. (2026). To kill two birds with one stone: a case report on the use of dupilumab in eczematous eruption and managing anti- PD-1 adverse effects in a melanoma patient. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 43(5), 584-587. https://doi.org/10.5114/ada.2026.165991
Chicago
Pawlus-Ruszel, Zuzanna, Mikołaj Łanocha, Wiktor Kruczek, Aleksandra Frątczak , Beata Bergler-Czop, and Bartosz Miziołek. 2026. "To kill two birds with one stone: a case report on the use of dupilumab in eczematous eruption and managing anti- PD-1 adverse effects in a melanoma patient". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 43 (5): 584-587. doi:10.5114/ada.2026.165991.
Harvard
Pawlus-Ruszel, Z., Łanocha, M., Kruczek, W., Frątczak , A., Bergler-Czop, B., and Miziołek, B. (2026). To kill two birds with one stone: a case report on the use of dupilumab in eczematous eruption and managing anti- PD-1 adverse effects in a melanoma patient. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 43(5), pp.584-587. https://doi.org/10.5114/ada.2026.165991
MLA
Pawlus-Ruszel, Zuzanna et al. "To kill two birds with one stone: a case report on the use of dupilumab in eczematous eruption and managing anti- PD-1 adverse effects in a melanoma patient." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 43, no. 5, 2026, pp. 584-587. doi:10.5114/ada.2026.165991.
Vancouver
Pawlus-Ruszel Z, Łanocha M, Kruczek W, Frątczak A, Bergler-Czop B, Miziołek B. To kill two birds with one stone: a case report on the use of dupilumab in eczematous eruption and managing anti- PD-1 adverse effects in a melanoma patient. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2026;43(5):584-587. doi:10.5114/ada.2026.165991.
